Symbols / DMRA Stock $25.42 -1.85% Damora Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
DMRA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Stock Fundamentals
Scroll to Statements
Market Cap 1.53B Enterprise Value 1.72B Income -209.84M Sales — Book/sh -110.11 Cash/sh 4.27
Dividend Yield — Payout 0.00% Employees 7 IPO — P/E — Forward P/E —
PEG — P/S — P/B -0.23 P/C — EV/EBITDA -47.09 EV/Sales —
Quick Ratio 12.88 Current Ratio 12.98 Debt/Eq 0.03 LT Debt/Eq — EPS (ttm) -3.98 EPS next Y —
EPS Growth — Revenue Growth — Earnings 2025-03-19 ROA -16.46% ROE -163.80% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 60.30M Shs Float 47.60M Short Float 1.38%
Short Ratio 2.98 Short Interest — 52W High 38.33 52W Low 2.45 Beta 1.60 Avg Volume 292.89K
Volume 99.53K Target Price $46.20 Recom None Prev Close $25.90 Price $25.42 Change -1.85%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-0.91
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest DMRA news

No recent news from Yahoo. Try the RSS feed for latest DMRA news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-30 JARRETT A JENNIFER Chief Executive Officer — 500,000 $0.00 $0
2026-02-09 FAIRMOUNT FUNDS MANAGEMENT LLC Director and Beneficial Owner of more than 10% of a Class of Security — 8,713,000 — —
2026-02-09 BRUNO JULIANNE Director — 129,000 — —
2026-01-05 HEWES LEMUEL BECKER Officer — 264,629 $0.00 $0
2026-01-05 SATTARZADEH SHERWIN Chief Operating Officer — 190,376 $0.00 $0
2026-01-02 SCHAMBYE HANS T. Chief Executive Officer — 700 $21.38 $14,966
2026-01-02 SCHAMBYE HANS T. Chief Executive Officer — 1,360 — —
2026-01-02 WINSLOW GARRETT General Counsel — 255 $21.38 $5,452
2026-01-02 WINSLOW GARRETT General Counsel — 680 — —
2026-01-02 FIRMANI LORI Chief Financial Officer — 135 $21.41 $2,890
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category